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A recombinant plasmid designated pLVS3 previously was described that harbored a 14-kilobase insert of
Treponemapallidum genomic DNA. Escherichia coli maxicells programmed with this plasmid synthesized three
treponemal protein antigens of molecular weights 39,000, 35,000, and 25,000 (39K, 35K, and 25K proteins,
respectively). In this study, a detailed deletion analysis of pLVS3 demonstrated that the genetic information for
all three protein antigens is contained within a 1.5-kilobase EcoRI-HpaI restriction fragment. The DNA
sequence of this fragment revealed a single open reading frame of 361 codons that most likely encodes a signal
peptide-bearing precursor to the 39K protein that can be transiently detected in E. coli maxiceils. Evidence
indicated that the 35K and 25K protein antigens are derivatives of the larger protein and are only produced in
maxicells. A significant elevation in expression of the 39K treponemal protein antigen in E. coli was obtained
by using the E. coli lpp and lac promoters and a genetic construction in which the signal peptide and first four
residues of the "mature" 39K protein were replaced by six amino acids encoded by the vector. This hybrid
protein exhibited an unusually high pl, which greatly facilitated its purification to homogeneity. By using
antibody prepared against the hybrid protein, the native treponemal protein counterpart, also of molecular
weight 39,000, was identified as a membrane component of T. paUidum. Since the native protein also exhibited
a net positive charge, it has been designated the T. pallidum basic membrane protein.
The bacterium Treponema pallidum, the etiological agent
of syphilis, cannot be continuously cultivated in vitro. To
obtain treponemes for experimental analyses, the organism
usually is cultivated in rabbit testes, from which it can be
extracted and purified in only limited quantities. For this
reason, little has been learned concerning the virulence
determinants of T. pallidum or about the immunogenic
determinants responsible for eliciting a protective host im-
mune response. Despite the experimental difficulties, re-
searchers have extensively compared the protein profiles of
various noncultivable and cultivable treponemal strains by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) and defined the various protein antigens of T.
pallidum that are reactive with sera from both infected
humans and rabbits at different times after infection (3, 5, 15,
16, 26, 30, 44, 47, 50). Several studies have attempted to
identify those protein antigens that reside on the treponemal
cell surface (1, 2, 21, 33, 35, 39, 44, 48), and it has been
suggested that several proteins serve as ligands involved in
the adherence of treponemes to host tissues (6, 37, 49). In
addition, a unique class of extracellular protein antigens of
T. pallidum has been identified (44).
In recent years, several laboratories have begun applying
recombinant DNA technology to the study of T. pallidum, in
hopes of at least partially circumventing problems associated
with the cultivation of this organism (11, 17, 31, 39, 43, 45,
46, 54). It was anticipated that recombinant treponemal
* Corresponding author.
t Present address: Department of Parasitology and Laboratory
Practice, School of Public Health, University of North Carolina,
Chapel Hill, NC 27514.
proteins would be conveniently produced in sufficient quan-
tities such that their role in syphilis and possibly other
human treponematoses could be defined and their applica-
bility as vaccinogens or improved serodiagnostic reagents
could be investigated.
A recombinant plasmid, pLVS3, was initially identified by
screening Escherichia coli clones for the expression of
antigens recognized in an in situ assay by high-titer rabbit
and human syphilitic sera (45). Subsequently, this plasmid
was found to encode three T. pallidum protein antigens of
molecular weights 39,000, 35,000, and 25,000 (39K, 35K, and
25K proteins, respectively) (46). Although the native T.
pallidum counterparts to these proteins were not known, the
39K protein was of particular interest for several reasons.
First, there was an indication that this protein is initially
synthesized with an amino-terminal signal peptide that
would direct this protein to some extracytoplasmic compart-
ment in E. coli and T. pallidum (46). Second, the evidence
indicated that E. coli cells harboring plasmid pLVS3 ex-
pressed treponemal antigens on their cell surface (43, 45).
Third, this protein was recognized by virtually every human
syphilitic serum tested, including sera from patients with
known primary, secondary, latent, and late cardiovascular
syphilis (46). Thus, it was thought that this protein might
have value as a serodiagnostic reagent for syphilis.
In this study, the nucleotide sequence of the gene encod-
ing the 39K protein has been determined. From this se-
quence and other data, the presence of a signal peptide is
strongly indicated. The coding sequence has been cloned
into an E. coli expression vector, facilitating purification of a
hybrid protein that includes nearly the entire "mature" 39K
protein. Rabbit immunoglobulin G (IgG) antibodies prepared
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against the purified protein precipitated a single, 39K mem-
brane protein from a solubilized, radiolabeled T. pallidum
cell extract. The purified, recombinant protein was found to
have an unusually high pI. Additional evidence indicated
that the native 39K protein also was quite basic. For these
reasons, the 39K protein encoded by plasmid pLVS3 has
been designated the T. pallidum basic membrane protein
(BMP).
MATERIALS AND METHODS
Bacterial strains, phage, and plasmids. M13 phage deriva-
tives and pUC8 derivatives were propagated in E. coli JM103
(32). All other plasmids were propagated in strain MM294
(ATCC 33625). Strain SE5000 (46) was used for maxicell
analyses in pulse-chase experiments. Strain MC4100 (9) was
used for protein purification. Phage M13mpl8 was used for
determining the bmp DNA sequence (32). The plasmid
pLVS3 is a pBR322 derivative harboring a 14-kilobase insert
of T. pallidum genomic DNA (27), and pUC8 is a plasmid
with a multiple cloning site region (52). The expression
vectors pIN-III-A2 and pIN-III-A3 have been described
previously (27). The source and cultivation of T. pallidum
(Nichols strain) were previously described (46).
DNA isolation, enzyme reactions, gel electrophoresis, and
transformation. Plasmid DNA was isolated using an alkaline
lysis method for both minipreparations and equilibrium
density centrifugation (38). All enzymes were purchased
from Bethesda Research Laboratories, Gaithersburg, Md.,
and restriction enzyme and ligase reaction conditions were
as described by O'Farrell et al. (34). Restricted DNA sam-
ples were analyzed on vertical agarose slab gels in Tris-
acetate buffer. Plasmid DNA was transformed into bacterial
strains by the method of Hanahan (14). DNA fragments were
isolated from agarose gels by the procedure of Lizardi et al.
(24).
Identification of recombinant T. pallidum protein antigens.
Plasmids were transformed into E. coli SE5000, and
[35S]methionine-radiolabeled maxicell extracts were pre-
pared as previously described (46). Recombinant treponemal
protein antigens were immune precipitated from solubilized
maxicell extracts by using high-titer experimental rabbit
syphilitic serum and analyzed by SDS-PAGE and fluorog-
raphy as previously described (46). [35S]methionine (trans-
lation grade; 1,154 Ci/mol) was obtained from New England
Nuclear Corp., Boston, Mass.
Plasmid derivatives of pLVS3. Deletion derivatives of
pLVS3 were isolated in two steps. Initially, pLVS3 was
digested with either HpaI, SstI, or EcoRI. The enzyme was
heat inactivated, the reaction mixture was diluted to a DNA
concentration of 20 ,ug/ml, and the ends of the plasmid were
rejoined with ligase. After transformation of the ligation mix
into strain MM294 cells, colonies were screened (38) for the
presence of plasmids that represented deletions of pLVS3.
The plasmid isolated after EcoRI deletion, designated
pTP020 (possessing only one EcoRl site), was used in
making additional deletions. The plasmid was linearized by
restriction with Sall, for which there is a single site within
the vector. The plasmid was then subjected to a second
digestion with either SstI, HpaI, or HindIII. All of the ends
were made blunt by treating the DNA with Klenow fragment
of DNA polymerase I in the presence of all four deoxyribo-
nucleotide triphosphates (8). As described above, the ends
of the plasmid were joined, and subsequent transformants
were analyzed for plasmid. Plasmid pTP022 (see Results)
was the plasmid derived from the Sall-SstI digest and was
shown to have a regenerated Sall site but no SstI site. As
predicted from the DNA sequence (see below), plasmids
from the other two double digests did not regenerate the
restriction sites used to make the deletions.
The unique HpaI site in pTP020 was converted to an
EcoRI site with an oligonucleotide (GGAATTCC) from New
England Biolabs, Beverly, Mass., that was incorporated as
described by Bahl et al. (4). A transformant having a plasmid
with two EcoRI sites and no HpaI site was identified and was
designated pTP027.
DNA sequence determination. An EcoRI fragment from
plasmid pTP027 was isolated and inserted into M13mpl8.
The insert could only be isolated in the orientation that
would not result in transcription of bmp. To sequence the
opposite strand with M13mpl8, the EcoRI fragment was
cloned as two EcoRI-MstI blunt-ended fragments into the
SmaI site. The DNA sequence was determined by the
strategy of Henikoff (19) and the chain-terminating method
of Sanger et al. (41). DNA was radiolabeled with 35S, and
reaction mixtures were electrophoresed on buffer gradient
gels (7). The sequence at the junction of expression vectors
and bmp was determined by the method of Maxam and
Gilbert (28).
Construction of plasmids pTP106 and pTP107. The gener-
ation of plasmid pTP106 is presented diagrammatically in
Fig. 1. A DdeI fragment (which included a PstI site) was
isolated from pTP025 DNA and cloned into plasmid pUC8
by filling in the DdeI ends and inserting the fragment into the
SmaI site. The insert orientation was determined by using a
Hinfl site (which overlapped the DdeI site by 3 base pairs
[bp]). The small PstI-HpaI fragment was cloned from
pTP020 into pUC8 between the PstI and HincIl sites,
forming pTPO07. A three-fragment ligation of the EcoRI-PstI
fragment from the first construction, the PstI-BamHI frag-
ment from pTP007, and EcoRI-BamHI-cleaved pIN-III-A2
DNA generated plasmid pTP106. Determination of the DNA
sequence from the XbaI site through the PstI site confirmed
the plasmid structure. Plasmid pTP107 was a 25-bp deletion
derivative of pTP106. The latter was restricted with both
XbaI and EcoRI, the ends were repaired, and the plasmid
was recircularized as described above. Both enzyme sites
were regenerated (as predicted, TCTAGAATTCC) in
pTP107, and the XbaI-PstI small fragment was shown to be
the same size as the EcoRI-PstI small fragment by agarose
gel electrophoresis.
Construction of plasmid pTP102. Plasmid pTP007 DNA
was restricted with PstI, the ends were made blunt, and the
EcoRI linker was inserted. The treponemal DNA was then
excised from the plasmid with EcoRI and BamHI and
inserted into the expression vector pIN-III-A3, forming
pTP102. The structure of the plasmid was confirmed by
DNA sequencing.
Pulse-chase experiments. Vigorously aerated 6-ml cultures
were grown in M63 minimal medium (29) with 0.2% glycerol
as the carbon source at 37°C to an optical density at 600 nm
of 0.2 and then induced with 2 mM isopropyl-p3-D-
thiogalactopyranoside. At 1 h postinduction, cells were
pulse-labeled with [35S]methionine (32.5 ,uCi/ml). The chase
was initiated by the addition of 1/10 volume of4% unlabeled
methionine. Samples (0.7 ml) were removed at the indicated
times and added to an equal volume of ice-cold 10% trichlo-
roacetic acid. The acid precipitates were pelleted, washed
once with 0.5 ml of acetone, and air dried. The pellets were
suspended, with a Bransonic 12 water bath sonifier, in 140 RI
of 10 mM Tris (pH 7.5)-l mM EDTA-1% SDS and solubil-
ized by heating for 4 min in a boiling water bath. A portion
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(50 ,ul) of the clarified supernatant of these samples was used
as the antigen extract in an immune precipitation procedure
identical to one previously described (46). Samples of 10 Rl
of rabbit anti-hybrid BMP (BMP*; see Results) IgG were
used for each precipitation reaction. Precipitates were ana-
lyzed by SDS-PAGE and fluorography as previously de-
scribed (46).
Purification of the BMP*. E. coli MM294 harboring plas-
mid pTP102 was grown in L broth (29) containing 50 mg of
ampicillin per liter at 35°C under forced aeration. The cells
were grown in 15-liter carboys to an optical density at 600
nm of 0.8 to 1.0, at which time isopropyl-p-D-thiogalactopy-
ranoside was added to a final concentration of 1.3 mM. After
an additional 2 h of incubation with inducer, cells (150 liters)
1470 bp











FIG. 1. Schematic diagram of the steps involved in constructing
expression plasmids. The EcoRI-HpaI fragment from pLVS3 is
shown at the top. A DdeI fragment was inserted into pUC8 at the
SmaI site, forming pTP089. A PstI-HpaI fragment was inserted into
pUC8 at the PstI and HincII sites, forming pTPOO7. For clarity, the
orientation of pTP007 is shown as the reverse of pTP089 (note the
arrows indicating the direction of transcription from the lac pro-
moter). An EcoRI-PstI fragment from pTP089, a PstI-BamHI frag-
ment from pTPOO7, and EcoRI-BamHI-cleaved pIN-III-A2 DNA
were joined to form pTP106. An expanded region of pIN-III-A2 is
shown with the lipoprotein gene and lactose operon (IppP and lacP),
the lactose operon operator (lacO), and the lipoprotein gene ribo-
some-binding site and initiation codon (rb and ATG). Arrows in
pTP106 indicate the direction of transcription for the ampicillin
resistance gene (bla), the lactose repressor gene (lacI), and the
1ppP-lacP double promoter. An XbaI-EcoRI deletion was made in
pTP106 to form pTP107. Abbreviations for restriction enzymes: E,
EcoRI; D, DdeI; P, PstI; Hp, HpaI; B. BamHI; Sm, SmaI; Hc,
HincII; X, XbaI.
were harvested with the Pellicon (Millipore Corp.). After
concentration to 3 liters, cells were centrifuged at 13,000 x
g for 15 min. The cell pellet (574 g) was suspended in a final
volume of 1,000 ml of 50 mM KPO4 buffer (50 mM dipotas-
sium phosphate adjusted to pH 7.3 with 50 mM monopotas-
sium phosphate) and disrupted by sonication (10 30-s
bursts). The total cell extract was centrifuged at 23,000 x g
for 1 h. The pellet was suspended in 400 ml of buffer with an
Omnimixer (Sorvall) and centrifuged again. The superna-
tants were combined (900 ml) and 342 g of solid (NH4)2SO4
was added to the crude extract as the extract was stirred at
4°C. After 30 min, the suspension was centrifuged at 13,000
x g for 20 min, and the supernatant was discarded. The
pellet was suspended in 200 ml of 50 mM KPO4 buffer and
dialyzed four times against 4 liters of the same buffer.
The dialyzed extract (415 ml) was pumped onto a 2.5- by
20-cm column of phosphocellulose that had been equili-
brated with the same buffer at a flow rate of 2.0 ml/min. The
column was washed with 300 ml of the same buffer. The
protein of interest was eluted from the column with 500 ml of
50 mM KPO4 buffer containing 0.2 M LiCl, and 20-ml
fractions were collected. The fractions were analyzed by
SDS-PAGE (23); the fractions containing the protein were
pooled (450 ml), precipitated with (NH4)2SO4, and dialyzed
three times against 2 liters of 25 mM KPO4 buffer (pH 7.4).
The dialyzed solution was passed through a 2.5- by 10-cm
column of DE-52, which was subsequently washed with the
same buffer. Fractions of 10 ml were collected, and the
absorbance at 280 nm was monitored. Those fractions with
an absorbance of greater than 0.05 were pooled and lyophi-
lized. The residue was resuspended in H20 to a total volume
of 40 ml; 10-ml samples were chromatographed on a 2.5- by
100-cm G-200 Sephadex column equilibrated in 25 mM KPO4
(pH 7.4) at a flow rate of 12.5 ml/h, and 5-ml fractions were
collected. The absorbance at 280 nm was determined, and
once again those fractions with an absorbance greater than
0.05 were assayed by SDS-PAGE. Those fractions contain-
ing the BMP* were pooled, dialyzed against 4 liters of 10 mM
EDTA for 12 h, then dialyzed against H20 for 24 h, and
lyophilized.
Protein concentrations were determined by the method of
Lowry et al. (25) with bovine serum albumin as the standard.
The presence of the protein and its purity were determined
by SDS-PAGE (23); protein bands were stained and
destained by the method of Ferguson (12). Molecular weight
markers were obtained from Pharmacia Fine Chemicals,
Piscataway, N.J. The isoelectric point (pI) of the BMP* was
determined by isoelectric focusing as previously described
(40) with carrier ampholytes (Pharmylate pH 8 to 10.5 with
10% Pharmylate pH 6 to 8) obtained from Pharmacia.
Preparation of rabbit anti-BMP* serum. Antiserum to the
BMP* was obtained from male New Zealand White rabbits.
Purified BMP* (1 mg) was suspended in phosphate-buffered
saline and mixed 1:1 with incomplete Freund adjuvant to a
total volume of 1.0 ml. A 0.2-ml sample was injected into the
muscle of each hind leg; booster injections of purified BMP*
in phosphate-buffered saline alone were administered at
2-week intervals. After rabbits were bled, the IgG antibody
fraction was purified as previously described (10).
Identification of native BMP. Cells of T. pallidum that had
been freshly extracted from infected rabbit testes were
intrinsically radiolabeled with [35Slmethionine as previously
described (44). Treponemal fractions were prepared and
solubilized, and the native BMP was precipitated with rabbit
anti-BMP* IgG and analyzed by SDS-PAGE and fluorog-
raphy as previously described (44).
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FIG. 2. Schematic diagram of restriction enzyme recognition sites and deletion derivatives of plasmid pLVS3. The plasmid has been
linearized by cleavage with Sail, which cuts the plasmid once in the vector portion. The thickened line represents pBR322. The cross-hatched
line demarcates that region coding for the T. pallidum protein antigens, and the underlying arrow indicates the direction of transcription.
Listed at the left are deletion derivatives of pLVS3, and the + or - indicates whether or not cells carrying the plasmid express the 39K
protein. Solid bars show the extent of each deletion, and the column at right denotes the ends of each deletion. The superscript a indicates
plasmids that are deletion derivatives of pTP020 (see Materials and Methods). Abbreviations for restriction enzymes: S, Sall; P, PstI; E,
EcoRI; H, HindIII; B, BamHI; Hp, HpaI; Ss, SstI; Sm, SmaI.
RESULTS
Restriction map and deletion analysis of pLVS3. The re-
combinant plasmid pLVS3 was previously shown to consist
of two BamHI fragments of T. pallidum DNA (13,700 and
900 bp) inserted into the single BamHI site of pBR322 (45,
46). To initiate this study, a more detailed restriction map of
pLVS3 was generated (Fig. 2). By selectively deleting spe-
cific DNA fragments with restriction enzymes, a series of
smaller plasmids was obtained, some of which are
diagramatically presented in Fig. 2. The effect of each
deletion on the expression of the three treponemal protein
antigens was then evaluated by using E. coli maxicells to
detect plasmid-encoded proteins. The identity of the trepo-
nemal proteins was authenticated by immunoprecipitation of
radiolabeled maxicell extracts with experimental rabbit
syphilitic serum (Fig. 3). Deletion of either a 6,500-bp HpaI
fragment (plasmid pTP001) or a 3,600-bp SstI fragment
(plasmid pTP002) resulted in the concomitant loss of synthe-
sis of all three proteins. In contrast, all three proteins were
still expressed, albeit in lesser amounts, after deletion oftwo
EcoRI fragments totaling 6,700 bp (plasmid pTP020). This
latter plasmid was then used to generate additional deletions,
each extending from the unique SalI site located in the
vector portion to an SstI site (plasmid pTP022), an HpaI site
(pTP025), or an HindIII site (pTP024). Maxicell analysis of
each of these plasmids revealed that only the 8,500-bp
Sall-HindIII deletion abolished expression of all three pro-
tein antigens. Neither of the other deletions eliminated
expression of any of the proteins, although the 8,000-bp
SalI-SstI deletion in plasmid pTP022 did result in the appear-
ance of an additional higher-molecular-weight immunoreac-
tive protein antigen (Fig. 3). Note that pTP025 was the
smallest plasmid that, when analyzed in maxicells, encoded
each of the three treponemal protein antigens of the parental
plasmid pLVS3. The size of the DNA insert in pTP025 was
estimated to be approximately 1,470 bp, which is insufficient
to encode successive genes for the three treponemal protein
antigens. However, it would be adequate to encode the
largest of the three, a protein of molecular weight 39,000.
Note that there have been at least two distinct treponemal
proteins identified in different laboratories as the "39K"
protein (33, 46). Since the 39K protein encoded by plasmid
pLVS3 has been shown to exhibit an unusually high pI (see
below), this protein will henceforth in the text be referred to
as the BMP of T. pallidum. The DNA sequence encoding
this protein has been designated the bmp gene.
Elevated expression of the BMP. The 1,470-bp fragment
was bounded by an EcoRI site and an HpaI site. In an effort
to obtain elevated synthesis of the recombinant treponemal
proteins in E. coli, this fragment was inserted into the
expression vector pIN-III-A2, which uses the E. coli lipo-
protein (lppP) and lacUV5 promoters to enhance transcrip-
tion of cloned DNA (27). These promoters are followed by
the lactose operator (lacO), which permits the regulation of
transcription of distal genes by the lactose repressor, whose
structural gene is also included on the vector. The HpaI site
at one end of the 1,470-bp fragment was converted to an
EcoRI site by adding an EcoRI linker to pTP020, thus
permitting insertion of the fragment into the unique EcoRI
site of plasmid pIN-III-A2 in both possible orientations.
Plasmid isolates corresponding to the two insert orientations
were identified by restricting with HindIII. Gene expression
from two representative plasmids was then analyzed in
maxicells (Fig. 4). For just one of these plasmids (pTP109),
the presence of isopropyl-,3-D-thiogalactopyranoside re-
sulted in enhancement of expression of the BMP, indicating
A B C D E F G
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FIG. 3. T. pallidum protein antigens epressed by plasmid pLVS3
and its deletion derivatives. Plasmid-encoded, [355]methionine-
radiolabeled recombinant treponemal protein antigens were immune
precipitated from solubilized E. coli maxicell extracts and analyzed
by SDS-PAGE and fluorography. Only the relevant portion of the
gel is shown. Lanes: A, pLVS3; B, pTP001; C, pTP002; D, pTP020;
E, pTP022; F, pTP025; G, pTP024. Protein antigens of 39K, 35K and
25K can easily be discerned in lane A. Note that longer exposure of
this gel clearly revealed synthesis of all three protein antigens by
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that the direction of transcription of the bmp gene is from the
EcoRI site toward the HpaI site (Fig. 2).
The nucleotide sequence of the entire EcoRI-HpaI frag-
ment of pLVS3 was determined (Fig. 6). An ATG codon was
identified at nucleotide 285 (numbering from the EcoRI site),
which was preceded by a putative ribosome binding site
(GGAG; nucleotides 276 through 279 [42]) and followed by a
long open reading frame capable of encoding a protein of 361
residues. This was the only large open reading frame en-
countered in this DNA fragment and thus must represent the
bmp gene. Interestingly, note that the SstI site used to
generate plasmid pTP022 resides just within the 3' end of the
coding sequence. Thus, the somewhat anomalous gel behav-
ior of the recombinant BMP in maxicells programmed with
this plasmid must result from generation of a recombinant
protein with a new carboxy terminus (see above).
As described in Materials and Methods, plasmid pTP107
was constructed, in which the BMP coding sequence from
plasmid pLVS3 was placed just downstream from the lacO
sequence of plasmid pIN-III-A2. Maxicells programmed
with plasmid pTP107 produced a somewhat greater quantity
of the BMP than did maxicells programmed with plasmid
pTP1O9 (Fig. 4). This result suggested that the ATG codon at
nucleotide 285 was indeed the initiating codon for the BMP.
BMP is initially expressed in E. coli in a precursor form.
When the production of the BMP was assayed in whole E.
coli cells containing plasmid pTP107, only a small amount of
this protein was made. This may be due to an inefficient
ribosome-binding site provided by the native treponemal
gene. Also, the possibility was considered that low expres-
sion was due in part to the localization of this protein when
expressed in E. coli. It previously had been suggested that
the BMP was synthesized in E. coli with an amino-terminal
signal peptide that was subsequently cleaved (46). Pulse-
chase studies revealed that the BMP was initially synthe-
sized in maxicells as a larger-molecular-weight precursor
form that was slowly processed to its 39K "mature" size
(Fig. SA). Evidence that this higher-molecular-weight form
represents an unprocessed signal peptide-bearing precursor
is supported by the observation that only this form of the
protein was observed when maxicells were labeled in the
presence of membrane perturbants, either 0.3% phenethyl
alcohol or 10% ethanol, treatments which are known to
inhibit signal peptide processing in E. coli (13; data not
presented). Attempts to unambiguously determine the intra-
cellular location of the BMP synthesized in E. coli maxicells
containing any of the plasmids described above thus far have
been unsuccessful, due to the instability of the protein when
these cells have been disrupted under nondenaturing condi-
tions (data not presented).
Assuming that the ATG codon at nucleotide 285 initiates
A B C D E
FIG. 4. Synthesis of BMP and BMP* by recombinant plasmids.
Plasmid-encoded [35S]methionine-radiolabeled recombinant trepo-
nemal protein antigens were immune precipitated from solubilized
E. coli maxicell extracts and analyzed by SDS-PAGE and
fluorography. Only the relevant portion of the gel is shown. Lanes:
A, pTP111; B, pTP109; C, pTP107; D, pTP106; E, pTP102. Note
that plasmids pTP111 and pTP109 harbor the 1,470-bp EcoRI-HpaI
fragment in opposite orientations. Plasmid pTP106 was an interme-
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FIG. 5. Pulse-chase analysis of recombinant treponemal protein
antigens expressed in E. coli. Cells of E. coli SE5000 harboring
either plasmid pTP107 (A) or pTP102 (B) were pulse-labeled for 30
s with [35S]methionine. At the indicated chase times, samples were
taken, total protein was acid precipitated, the recombinant trepone-
mal protein antigen was immune precipitated, and the precipitates
were analyzed by SDS-PAGE and fluorography (see Materials and
Methods).
translation of the BMP, translation of the downstream DNA
sequence revealed a primary amino acid sequence of 20
residues that is fairly typical of procaryotic signal peptides
(Fig. 6) (53). This putative signal peptide includes a charged
residue very near its amino terminus followed by a fairly
long hydrophobic core and, last, the sequence Ala-X-Ala,
which precedes the cleavage site in many nonlipoprotein
signal peptides in E. coli (36, 53). Just beyond this coding
region, the DNA sequence identified a PstI site (Fig. 6).
Using this restriction site we generated in vitro a deletion
that removed the putative signal peptide-coding region, and
subsequent manipulations directed translational initiation of
the remaining sequence at a site early in the coding region for
the mature BMP (see Materials and Methods). In this
plasmid, designated pTP102, translation of the 39K protein
was initiated at the lipoprotein ribosome-binding site, and
the first four residues of the mature BMP were replaced by
six amino acids encoded by the vector (Fig. 7). This hybrid
protein was designated BMP*. When plasmid pTP102 was
analyzed in maxicells, enhanced expression of the BMP*
was observed (Fig. 4). As expected, a precursor form for this
protein was not discerned in a pulse-chase experiment (Fig.
SB).
Purification of the recombinant BMP* encoded by plasmid
pTP102. When whole cells of strain MM294 harboring plas-
mid pTP102 were analyzed by SDS-PAGE and Coomassie
blue staining, the BMP* could easily be discerned (Fig. 8).
Interestingly, synthesis of the 25K and 35K treponemal
protein antigens was not detected. We estimated that pro-
duction of this protein was elevated approximately 10-fold
above the level observed in cells harboring plasmid pTP107.
Cells of strain MM294 (pTP102) were disrupted by sonica-
tion, and crude membrane and soluble fractions were pre-
pared and analyzed by SDS-PAGE. Under these conditions,
the bulk of the BMP* was clearly in the soluble fraction.
The BMP* was purified to homogeneity by conventional
techniques, as described in detail in Materials and Methods.
Initially after the soluble and membrane wash fractions were
pooled and precipitated with (NH4)2SO4, the dialyzed ex-
tract was applied to a chromatofocusing column. The protein
did not bind to this resin, suggesting that the isoelectric point
of this protein was above 7.5. A phosphocellulose resin was
then utilized, since it has a high capacity for basic proteins
and most native E. coli proteins are acidic. Binding of the
protein to phosphocellulose and batch elution of the protein
with 0.2 M LiCl resulted in approximately a 100-fold purifi-
cation. Further purification of the protein to apparent homo-
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EcoRI * 80
GAATTCTGGTGCCGTGGCGTTGTTTGGTGAGAAATACGAATCAACTGTAAAGGTGTACTCCATAGGAACTTTTCTCGGG
* * * * * * * 160
AAGTGTGTGGCGGTCCACATGTAGCACGTACCGGGCAGCTCGGGCGGTTTTCTATTCAAAAGGAACAGTCGAGTGCGGCG
* * * * * * * 240
GGGGTGCGGCGTATTCGCGCGATTCTTGAGAAAAGCGGGGAAAAGTCGTAACTTGCCCTGCTGCGTATAGTTTCTCCGGC
* DdeI * * * * * * 320
GTGTGTGCTGGTGACTGAGTCGCGGTTGTTTACGGGGAGTTCTCATGGGCAGATACATAGTTCCCGCTCTGTTGTGCGTG
MetGlyArgTyrIleValProAlaLeuLeuCysVal
* PstI. * ** 400
GCGGGTATGGGTTTGCGCACGCGCAGTCGGCGCTGCAGCCTATCGCCGAAGTGAATMTATTCCGGCGTGAGCCGGTGAC
AlaGlyMetGlyPheAlaHi sAlaGlnSerAlaLeuGlnProIl eAlaGl uValAsnLeuPheArgArgGl uProVal Th
* * * * * DdeIe * 480
GCTCGGACAGATTAAGGCAAGAATTTCTGCGATTGAGAAAGAGATGGGAAAGAAGCTCAGCACTGCTGAGCGTAGACAAT
rLeuGlyGlnIleLysAlaArgIleSerAlaIleGl uLysGluMetGlyLysLysLeuSerThrAlaGl uArgArgGlnP
* * HindIIIo * * * 0 560
TCATGGACAGTCTTATTGACGAAAAGCTTTTTGcTcAAGcGGcAGAAAAGGcGGGTATCCAGGTAACGGATGCTGAAGTG
heMetAspSerLeuIleAspGl uLysLeuPheAlaGlnAlaAlaGl uLysAlaGlyIleGlnVal ThrAspAlaGl uVal
* * * * * * * 640
AATCAGTATTTTAATGGAATGCTTTCTCAACAGATTGGACGTGCGGTAACGGAGGCTGAGTCGCCAATTACGTCAAGGA
AsnGlnTyrPheAsnGlyMe tLeuSerGlnGlnIleGlyArgAla Val ThrGl uAlaGl uPheAlaAsnTyrValLysGl
* * * * * * * 720
GAAGCAGAATATCTCGCTCGATCAGTTCATGAAGCAGCAAAACGGCATGACTATGGCAGMATACAAAAAGTTTCTAAAGA
uLysGlnAsnIleSerLeuAspGlnPheMe tLysGlnGlnAsnGlyMe tThrMe tAlaGl uTyrLysLysPheLeuLysT
* * * * * * * 800
CGCAGGTGAGCACGCAGCGcTACGTGGCAcAAAAGAAGGCAGACGAGTTmCGGAAmTTTGAGGGACCTGAGGACTCTCAA
hrGlnValSerThrGlnArgTyrValAlaGlnLysLysAlaAspGl uPheArgAsnLeuLysGlyProGl uAspSerGln
* * * * * * * 880
ATCCGTTCCTACTACGAGCTTAATAAACAGGCCTTTTTCCGCCCTGACACGGTTAAGTTGTTTCTTATTTCTGTCCCGAA
IleArgSerTyrTyrGl uLeuAsnLysGlnAlaPhePheArgProAspThrValLysLeuPheLeuIleSerValProLy
* * * * * * * 960
GGGTTCAGGTCCTGCTGCTGCAAAGGCGAAAGCGCAAGAGTTTGTTAAGAAACTTAAAAGTTCCGGTGTCAAAGCCACGG
sGlySerGlyProAlaAlaAlaLysAlaLysAlaGlnGl uPheValLysLysLeuLysSerSerGlyValLysAlaThrA
* * * * * * * 1040
CTGACATTAAGAGTAAGGCAAATGGTGCACAGGCGGGTTACTCTGCCGGGGAAATATACCTGGGGAAGACTGCGGTTACT
laAspIleLysSerLysAlaAsnGlyAlaGlnAlaGlyTyrSerAlaGlyGl uIleTyrLeuGlyLysThrAlaVal Thr
* * * * * * * 1120
GCCACGCAGCTTGGTCTGACGATGGAGGCGTTGCTTGAAATTTTTGGCATGGGAGTTGGTGCTGTTTCGGACGTGAATGA
AlaThrGlnLeuGlyLeuThrMetGl uAlaLeuLeuGl uIlePheGlyMtetGlyValGlyAlaValSerAspValAsnGl
* * * * * * * 1200
AACGGCTAATGACTATCAGTGCTTCATAGTTTTGAAGAAAGAGGAAGCGAAGATCCTAACGCTCAGCGATTTGGTGGAGC
uThrAlaAsnAspTyrGlnCysPhenleValLeuLysLysGluGl uAlaLysnleLeuThrLeuSerAspLeuValGl uP
* . * * * * * 1280
CTGACAAGACCGTCTCGCTTTACGAGTTTATCAAGAATCTTCTTACTTCCCAAATCCAACAAAAAGCGCTCGAGGACGCT
roAspLysThrValSerLeuTyrGluPheIleLysAsnLeuLeuThrSerGlnnleGlnGlnLysAl aLeuGluAspAla
* . * * * * SstI * 1360
ATCCGGGAAGTGTCGGCGGAGCTGAGGAAGTCTGGTACCTATAAGGTATrCTTGGCTGACGCAGAGCTCGGCAAGGTGCT
IleArgGluValSerAlaGluLeuArgLysSerGlyThrTyrLysValPheLeuAlaAspAlaGltuLeuGlyLysValLe





FIG. 6. Nucleotide sequence of the EcoRI-HpaI 1,470-bp fragment from pLVS3. Only the sense strand is given. The locations of
restriction enzyme recognition sites used to make deletions or to construct expression plasmids are indicated. The predicted amino acid
sequence of the bmp translation product is shown below the DNA sequence.
geneity was obtained by DE-52 column chromatography (the upon standing, even in the presence of 50 mM KPO4 (pH 7
BMP* does not bind) and by molecular sieving (the BMP* to 9) and 1% Triton X-100. The sequence of the amino-
migrates either as a monomer or dimer but not as an terminal 25 residues of the purified protein has been deter-
aggregate). mined (data not presented). This sequence corresponded
A summary of the purification procedure is shown in Table with what was predicted from the DNA sequence and the
1, and an SDS-PAGE analysis of the purified BMP* is genetic construction that yielded plasmid pTP102.
presented in Fig. 8. The purified protein has an isoelectric Identification of the native BMP of T. pallidum. Rabbit IgG
point of 9.5 and an apparent monomer molecular weight of antibody directed against the purified recombinant BMP*
39,000 as determined by SDS-PAGE. After purification, the was prepared as described in Materials and Methods. The
protein tended to aggregate and precipitate from solution antibody precipitated each of the three treponemal protein
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antigens detected in maxicell extracts of plasmid pLVS3
(data not presented), further indicating that the two smaller
proteins are somehow derived from the larger 39K BMP. In
addition, this same IgG preparation was used in an immune
precipitation reaction with an antigen extract prepared from
whole cells of T. pallidum that had been radiolabeled in vitro
with [35S]methionine (see Materials and Methods). A single
treponemal protein of approximately 39K was precipitated
(Fig. 9). This protein migrated on SDS-PAGE to the same
position as the processed BMP encoded by plasmid pTP107
(data not presented). The native BMP was found almost
exclusively in the particulate treponemal fraction (Fig. 9). A
treponemal membrane extract and purified BMP* were
solubilized in a buffer containing Triton X-100 and electro-
phoresed on an analytical agarose gel at pH 7.8. Subse-
quently, proteins were transferred from the agarose gel to
nitrocellulose paper and probed with anti-BMP* IgG. Both
the native BMP and recombinant BMP* were found to
migrate in an identical manner toward the cathode, indicat-
ing that both proteins exhibited what appeared to be an
identical net positive charge (data not presented). Finally,
attempts to precipitate a protein from solubilized extracts
prepared from radiolabeled cells of the cultivable treponemal
strain T. phagedenis biotype Reiter were unsuccessful (data
not presented).
DISCUSSION
The nucleotide sequence indicates that the 1,470-bp
EcoRI-HpaI fragment of recombinant plasmid pLVS3 en-
codes a single treponemal protein of 361 residues with a
compositional molecular weight of 39,940. It appears that
this protein includes an amino-terminal signal peptide of 20
residues, assuming that processing occurs immediately after
the Ala-His-Ala sequence that resembles the processing site
for E. coli leader peptidase (36, 53). Assuming that this is
correct, then the processed form of the protein would have
341 residues with a compositional molecular weight of
37,880, which is very close to the 39,000 molecular weight
estimated for this protein from analysis on SDS-PAGE. The
recombinant BMP* that was purified from E. coli and that
differs only slightly from the native treponemal protein
exhibited an unusually high isoelectric point of 9.5, which
greatly facilitated its purification. The high pl is not reflected
in the protein's primary amino acid sequence, where basic
residues outnumber acidic residues only slightly (48 versus
43).
In both this study and a previous study (46), E. coli
maxicells programmed with plasmid pLVS3 produced three
treponemal protein antigens, 39K, 35K, and 25K. However,
a deletion analysis of this plasmid clearly demonstrated that
all three proteins were encoded on a DNA fragment of
insufficient size to include separate genes for these three
proteins. Since the DNA sequence of this fragment revealed
only a single large open reading frame, and since all three
EcoRI
ATG AAA GGG GGA ATT CCVG2 CCT ATC GCC
BMP* Met Lys Gly Gly nle Pro Pro nle Ala
BE Gln Ser Ala Leu Gln Pro nle Ala
FIG. 7. Nucleotide sequence at the junction of the expression
vector and bmp in pTP102. Cl is the last nucleotide of the synthetic
EcoRI octomer that was added at the Pstl site of bmp. G2 is the last
nucleotide of the PstI site (CTGCAG2). The amino-terminal se-
quence for BMP* is shown below the nucleotide sequence. The
predicted amino terminal sequence for mature BMP is also
provided.
A B C D
FIG. 8. SDS-PAGE of purified BMP*. Cells of E. coli MM294
harboring either plasmid pIN-III-A3 (vector control) or pTP1O2
were grown, induced, and disrupted as described in Materials and
Methods. The crude extract was centrifuged at 13,000 x g for 15
min, and a 5-1jl sample of the clarified extract obtained from the
control strain (lane A) or the extract containing the BMP* (lane B)
were mixed with sample buffer, boiled, and analyzed by SDS-
PAGE. BMP* was purified as described in Materials and Methods;
samples of 15 p.g (lane C) and 2.5 ~±g (lane D) of the purified material
(Table 1) were analyzed on the same gel. Note that there is a second
protein species that migrates just below the BMP* (lane B) that also
appears to be encoded by plasmid pTP102. This is believed to
represent a breakdown product of the BMP*.
proteins can be precipitated by antibody prepared against
the purified BMP*, one must conclude that the 25K and 35K
proteins are derivatives of the larger 39K BMP. In pulse-
chase studies with maxicells, all three proteins radiolabeled
simultaneously and were quite stable; there was no evidence
that the smaller proteins arose from the proteolytic break-
down of the larger protein (data not presented). Only the
39K BMP was detected in untreated E. ccli cells (i.e., not
maxicells) and radiolabeled cells of T. pallidum. Thus, it
appears that the synthesis of the 35K and 25K protein
antigens is an artifact of the maxicell procedure. It could be
that the smaller proteins result from translational restarts
within the BMP message when it is expressed in E. coli
maxicells. There are ATG codons at nucleotides 444 and 669
of the EcoRI-HpaI fragment that might serve as translation
initiation sites for synthesis of the 35K and 25K proteins,
respectively.
The very slow processing observed for the BMP when it is
synthesized in E. ccli cells is somewhat intriguing. Similar
kinetics of processing have been noted in this laboratory for
a number of cloned treponemal proteins expressed in E. ccli
TABLE 1. Purification of the recombinant BMP* produced in
cells of E. coli MM294'
Fraction Vol (ml) Protein (g)
Crude lysate 900 68.8
Phosphocellulose load 415 39.3
Phosphocellulose pool 450 0.357
DE-52 effluent 600 0.240
G-200 pool 164 0.174
a The purification of the BMP* was followed by SDS-PAGE (Fig. 8). The
overall yield based on scanning the crude lysate was approximately 50%.
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FIG. 9. Identification and celli
cell, soluble, and membrane fr;
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PAGE, and fluorography. For ea
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containing 1% SDS; B, precipi
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(Stamm, unpublished data).
bearing proteins are normally
cotranslationally or very sh
translation (22), such a resu]
treponemal proteins are not e
coli export machinery. It c(
signals used for determining t]
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solubilized, radiolabeled T. I
grated identically on SDS-PA
part produced in E. coli m.
protein is synthesized in E. cl
subsequently processed and
protein appears to reside i
fraction strongly indicates th
the T. pallidum cell envelope.
primary amino acid sequence
that is predominantly hydrc
include several small hydrol
hydrophobic region that exte
255 of the mature sequence.
been developed to prepare s
brane fractions from T. pallic
have indicated that the BMP*
SOLUBLE MEMBRANE surface of treponemes that have been radiolabeled in vitro
(Stamm, unpublished data). Because of its high pI and
A C D A C D possible cell surface location, it is tempting to speculate that
this protein could be involved in the attachment of
treponemes to host tissues. Although the BMP does not
appear to be a major treponemal protein, previous studies
indicated that it is quite immunogenic in infected humans
and rabbits (46). Potential functional roles for this BMP of T.
* < ^ *, pallidum in the pathogenesis of syphilis are currently being
investigated.
* _ * * There also is a potential application for the purified BMP*
I ^ treponemal antigen produced by E. coli as a highly specific
1 0 3= _ reagent for the serodiagnosis of syphilis and other human
A if^ ^treponematoses. Previously, it was demonstrated that the
W=w w great majority of human syphilitic and yaws sera tested,I } § _ regardless of disease stage, were capable of precipitating the
It w tBMP from maxicell extracts programmed with plasmid
pLVS3 (46). All of the normal human sera tested in like
manner were nonreactive. In addition, sera from rabbits
immunized with cells of the cultivable treponeme T.
m WV e phagedenis biotype Reiter did not recognize this protein,
* * suggesting that the BMP may represent a pathogen-specific
antigen (46). This was further established by the failure of
antisera prepared against the purified recombinant protein to
precipitate any proteins from solubilized Reiter cell extracts.
Many normal human sera contain antibodies that cross-react
ular location of native BMP. Whole with T. pallidum antigens and presumably arise in response
actions of [35S]methionine-labeled to antigens of the normal bacterial flora (18). The use of a
he presence of the native BMP was pathogen-specific antigen would eliminate the requirement
radioimmunoprecipitation, SDS- for absorbing human sera with an extract prepared from
Lch fraction, the order of presenta- Reiter treponemes, as is now done for most commonly used
me fraction solubilized in buffer confirmatory tests for syphilis (20, 51).
itate obtained with normal rabbit This study does not include data concerning the analysis
with high-titer experimental rabbit
of the cloned T pallidum DNA sequence for the identifica-
am control is presented only for the tion of potential transcription and translation signals that
might be employed by this organism or for preferential
codon usage. The sequences of cloned DNA fragments
encoding two additional T. pallidum protein antigens of 56K
Since E. coli signal peptide- and 34K recently have been determined (Dallas, unpublished
exported and processed either data). A detailed analysis of all three treponemal genes in
ortly after the completion of this regard will be presented elsewhere.
It strongly suggests that these Finally, this study represents the third instance in which a
-fficiently recognized by the E. protein antigen of T. pallidum has been expressed in E. coli
ould well be that the various and the recombinant protein has been purified. Lovett and
he ultimate cellular location for co-workers (11, 39) have purified and characterized a protein
and T. pallidum, two procary- antigen designated 4D, a polymer of identical 19K monomers
related, are considerably dif- that forms an ordered ring structure of 10 nm diameter and
that appears to coat the treponemal outer surface. van
prepared against the purified Embden and co-workers have cloned and sequenced a
itated a single protein from treponemal gene designated tmpA that encodes a 44K trep-
,allidum cell extracts that mi- onemal membrane protein, which appears also to exhibit
LGE, as did its cloned counter- slow signal peptide processing when expressed in E. coli
axicells. The finding that this (17). A cro-TmpA-,B-galactosidase sandwich protein was
oli with a signal peptide that is engineered and purified and currently is being tested for
that the great majority of this possible uses as a serodiagnostic reagent (17). Thus, it is
in the particulate treponemal apparent that the difficulties in obtaining suitable quantities
at the BMP is a component of of T. pallidum cells for experimental studies can be at least
A hydrophilicity profile of the partially circumvented by employing recombinant DNA
(not shown) reveals a protein technology. We anticipate that the analysis of recombinant
)philic in character but does treponemal antigens will provide new insights into the patho-
phobic regions and one large genesis and immunobiology of T. pallidum infection.
nds from residues 214 through
To date, techniques have not
,eparate inner and outer mem-
tum cells, but preliminary data
is prominantly exposed on the
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